Journal of Bone Oncology
短名 | J. Bone Oncol. |
Journal Impact | 3.05 |
国际分区 | ONCOLOGY(Q2) |
期刊索引 | SCI Q3中科院 2 区 |
ISSN | 2212-1366, 2212-1374 |
h-index | 36 |
国内分区 | 医学(2区)医学肿瘤学(3区) |
JOURNAL OF BONE ONCOLOGY 是一本经过同行评审的国际期刊,旨在展示与骨骼和癌症相关的基础、转化和临床高质量研究。作为第一本致力于癌症诱发的骨骼疾病的期刊,JBO 欢迎原创研究文章、评论文章、社论和评论文章。病例报告仅在特殊情况下才会考虑,并且只有在对主题进行全面审查时才会考虑。期刊涵盖的领域包括:骨转移(病理生理学、流行病学、诊断学、临床特征、预防、治疗)转移的临床前模型骨微环境在癌症(干细胞、骨细胞和癌症相互作用)骨靶向治疗(药理学、治疗靶点、药物开发、临床试验、副作用、结果研究、健康经济学)癌症治疗引起的骨丢失(流行病学、病理生理学、预防和管理) )骨成像(临床和动物、骨骼介入放射学)骨生物标志物(临床和转化应用)放射治疗和放射性同位素骨骼并发症骨痛(机制和管理)骨科癌症手术原发性骨肿瘤临床指南多学科护理关键词:双膦酸盐、骨、乳腺癌、癌症、CTIBL , 地诺塞麦, 满足肿瘤、骨髓瘤、成骨细胞、破骨细胞、骨肿瘤学、骨肿瘤学、前列腺癌、骨骼、肿瘤。
期刊主页投稿网址涉及主题 | 医学生物内科学病理遗传学外科癌症癌症研究化学生物化学肿瘤科乳腺癌放射科转移内分泌学免疫学前列腺癌骨肉瘤数学基因 |
出版信息 | 出版商: Elsevier GmbH,出版周期: ,期刊类型: journal |
基本数据 | 创刊年份: 2012,原创研究文献占比: 75.47%,自引率:3.20%, Gold OA占比: 96.61% |
平均审稿周期 | 网友分享经验:20 Weeks |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Radiographic imaging and diagnosis of spinal bone tumors: AlexNet and ResNet for the classification of tumor malignancy
2024-10-1
Groenlandicine enhances cisplatin sensitivity in cisplatin-resistant osteosarcoma cells through the BAX/Bcl-2/Caspase-9/Caspase-3 pathway
2024-10-1
Improved localization and segmentation of spinal bone metastases in MRI with nnUNet radiomics
2024-10-1
Preliminary discrimination and evaluation of clinical application value of ChatGPT4o in bone tumors
2024-9-1
Does liquid nitrogen recycled autograft for treatment of bone sarcoma impact local recurrence rate? a systematic review
2024-8-8
Mometasone furoate inhibits tumor progression and promotes apoptosis through activation of the AMPK/mTOR signaling pathway in osteosarcoma
2024-8-1
Urinary biomarkers in metastatic bone pain: Results from a multicentre randomized trial of ibandronate compared to single dose radiotherapy for localized metastatic bone pain in prostate cancer (RIB)
2024-8-1
An enhanced AlexNet-Based model for femoral bone tumor classification and diagnosis using magnetic resonance imaging
2024-8-1
Senescence in the bone marrow microenvironment: A driver in development of therapy-related myeloid neoplasms
2024-8-1
Pharmacologic Hedgehog inhibition modulates the cytokine profile of osteolytic breast cancer cells
2024-8-1
Radiomic nomogram for predicting high-risk cytogenetic status in multiple myeloma based on fat-suppressed T2-weighted magnetic resonance imaging
2024-8-1
Comprehensive diagnostic model for osteosarcoma classification using CT imaging features
2024-8-1
Real-world experiences in patients with Ewing sarcoma treated at a specialist centre in Turkey
2024-8-1
Automated measurement of lumbar pedicle screw parameters using deep learning algorithm on preoperative CT scans
2024-8-1
The survival and complication profiles of the Compress® Endoprosthesis: A systematic review and meta-analysis
2024-7-16
Bone niches in the regulation of tumour cell dormancy
2024-7-6
Impact of quantitative CT texture analysis on the outcome of CT-guided bone biopsy
2024-6-19
The impact of androgen deprivation therapy on bone microarchitecture in men with prostate cancer: A longitudinal observational study (The ANTELOPE Study)
2024-6-18
Percutaneous vertebroplasty/kyphoplasty contributes to the improved outcome in patients with newly diagnosed multiple myeloma: A single center cohort study
2024-6-16
Preoperative prediction of high-grade osteosarcoma response to neoadjuvant therapy based on a plain CT radiomics model: A dual-center study
2024-6-9
From bimodal to unimodal: The transformed incidence of osteosarcoma in the United States
2024-6-6
Reversine inhibits proliferation and induces apoptosis of human osteosarcoma cells through targeting MEK1
2024-6-1
Single-cell transcriptional profiling in osteosarcoma and the effect of neoadjuvant chemotherapy on the tumor microenvironment
2024-6-1
The role of IL-1B in breast cancer bone metastasis
2024-6-1
Adipocytes and metabolism: Contributions to multiple myeloma
2024-6-1
Emerging roles for stromal cells in bone metastasis
2024-5-17
Trends in primary malignant bone cancer incidence and mortality in the United States, 2000–2017: A population-based study
2024-5-12
Automatic classification of spinal osteosarcoma and giant cell tumor of bone using optimized DenseNet
2024-5-11
FBXO22 is a potential therapeutic target for recurrent chondrosarcoma
2024-5-1
Incidence, risk Factors, and survival of bone metastases and Skeletal-Related events in melanoma Patients: A systematic review and quality assessment of 29 studies
2024-4-22
#37. Lactate-GPR81 signaling in acute myeloid leukemia (AML) contributes to bone marrow microenvironment dysfunction, macrophage polarization, and leukemia cell growth
2024-4-1
#38. Cholesterol increases bone marrow tumour burden in myeloma in vivo and promotes myeloma cell viability and bortezomib resistance ex vivo
2024-4-1
#10. Investigating the role of non-canonical Hedgehog signaling in paclitaxel-resistant bone- metastatic breast cancer
2024-4-1
#6. Mechanical loading of breast cancer laden bones alters osteocyte mediated bone loss in vivo
2024-4-1
#40. Bone metastatic cancer derived stem cell factor induces sensory nerve sprouting in vitro and pain behavior in vivo through c-kit receptor activation
2024-4-1
#18. Inhibition of de novo serine synthesis in osteosarcoma depletes cysteine and drives dependency upon exogenous cystine import through system xCT to maintain redox balance
2024-4-1
#34. The effect of dickkopf-1 (DKK-1) on prostate cancer growth and bone metastasis using the canine osteoblastic Probasco cell line
2024-4-1
#13. 3D printed bioactive glasses porous scaffolds with high strength for the repair of long-bone segmental defects
2024-4-1
#30. Fractures in metastatic hormone-sensitive prostate cancer (mHSPC). Results from two phase 3 trials from the STAMPEDE platform
2024-4-1
#11. Bone marrow adipocyte-induced increases in lipid content and fatty acid binding proteins may support proliferation in myeloma cells
2024-4-1
#23. Elucidating the role of bone marrow stiffness in estrogen signaling in metastatic breast cancer to the bone
2024-4-1
#50. Investigating the role of EphA2 in breast cancer bone metastasis
2024-4-1
#19. RANKL independent osteolysis in Adult T cell leukemia via small extracellular vesicles
2024-4-1
#39. Bone-derived Dickkopf-related protein 1 supports primary breast cancer growth and alters hematopoiesis
2024-4-1
CDK4/6 inhibitor and doxorubicin synergistically inhibit breast cancer bone metastasis and enhance T-cell targeted therapy
2024-4-1
Cancer-associated hypercalcemia signals through the hindbrain to cause anorexia
2024-4-1
#8. Radium-223 treated primary patient bone biopsy analysis: Macro to microscale analyses and dosimetry
2024-4-1
#22. Investigating the TGF-β/integrin β3 signaling axis as a mediator of chemoresistance in breast cancer bone metastasis
2024-4-1
#36. Novel therapeutic development with serine biosynthesis inhibition and molecularly targeted drugs against the aggressive osteosarcoma
2024-4-1
#21. PD-1 blockade induces bone loss and reduces bone strength in a breast cancer bone metastasis model
2024-4-1
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远